Effects of resveratrol nanocapsules on the quantitative insulin sensitivity check index in insulin resistance: a study on metabolic syndrome induce mice

[1]  H. Krauss,et al.  Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women. , 2018, Physiological research.

[2]  S. Bahadorikhalili,et al.  Resveratrol nano-capsule as an effi cient tool for blood pressure regulation: A study on metabolic syndrome induced mice , 2017 .

[3]  Luciana Mosca,et al.  Chemistry, stability and bioavailability of resveratrol. , 2014, Medicinal chemistry (Shariqah (United Arab Emirates)).

[4]  J. Finley,et al.  Antioxidants in foods: state of the science important to the food industry. , 2011, Journal of agricultural and food chemistry.

[5]  S. Guterres,et al.  Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. , 2010, Journal of biomedical nanotechnology.

[6]  R. Rabasa-Lhoret,et al.  HOMA or QUICKI: is it useful to test the reproducibility of formulas? , 2008, Diabetes & metabolism.

[7]  P. Nilsson,et al.  Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes , 2007, Journal of Human Hypertension.

[8]  W Greg Miller,et al.  Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. , 2007, Clinical chemistry.

[9]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[10]  P. Nilsson,et al.  The metabolic syndrome: a glance at its history , 2006, Journal of hypertension.

[11]  Hui Chen,et al.  Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. , 2005, Diabetes.

[12]  M. Reilly,et al.  The Metabolic Syndrome: More Than the Sum of Its Parts? , 2003, Circulation.

[13]  Hui Chen,et al.  QUICKI is a useful index of insulin sensitivity in subjects with hypertension. , 2003, American journal of physiology. Endocrinology and metabolism.

[14]  E. Kilpatrick,et al.  Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes. , 2002, Diabetes care.

[15]  E. Gabazza,et al.  QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. , 2002, The Journal of clinical endocrinology and metabolism.

[16]  M. Stumvoll,et al.  Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. , 2001, Diabetes care.

[17]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[18]  J. Brun,et al.  Revised concept for the estimation of insulin sensitivity from a single sample. , 1999, Diabetes care.

[19]  A. Avignon,et al.  Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state , 1999, International Journal of Obesity.

[20]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[21]  E. Ferrannini.  Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. , 1998, Endocrine reviews.

[22]  L. Bouter,et al.  Insulin and risk of cardiovascular disease: a meta-analysis. , 1998, Circulation.

[23]  G. Volpicelli,et al.  Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. , 1998, Molecular genetics and metabolism.

[24]  S. Haffner,et al.  Insulin resistance implications for type II diabetes mellitus and coronary heart disease. , 1997, The American journal of medicine.

[25]  S. Haffner,et al.  The Homeostasis Model in the San Antonio Heart Study , 1997, Diabetes Care.

[26]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[27]  P. Savage,et al.  Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. , 1995, American journal of epidemiology.

[28]  R N Bergman,et al.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.

[29]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[30]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[31]  C. Best.  The internal secretion of the pancreas. , 1922, Canadian Medical Association journal.

[32]  Félix M. Puchulu,et al.  Definition, Diagnosis and Classification of Diabetes Mellitus , 2018 .

[33]  V. Janout,et al.  Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. , 2002, The Journal of clinical endocrinology and metabolism.

[34]  C. Bogardus,et al.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. , 2001, Diabetes care.

[35]  J. Rood,et al.  Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. , 2001, Metabolism: clinical and experimental.